Faculty Opinions recommendation of Rituximab as potential therapy for paraneoplastic cerebellar degeneration in pediatric Hodgkin disease.
2000 ◽
Vol 22
(2)
◽
pp. 158-161
◽
1995 ◽
Vol 5
(5)
◽
pp. 396-399
◽
2010 ◽
Vol 291
(1-2)
◽
pp. 74-78
◽
1992 ◽
Vol 31
(12)
◽
pp. 1339-1342
◽